| Serial killing of tumor cells by human natural killer cells–enhancement by therapeutic antibodies R Bhat, C Watzl PloS one 2 (3), e326, 2007 | 336 | 2007 |
| Oncolytic H-1 parvovirus shows safety and signs of immunogenic activity in a first phase I/IIa glioblastoma trial K Geletneky, J Hajda, AL Angelova, B Leuchs, D Capper, AJ Bartsch, ... Molecular Therapy 25 (12), 2620-2634, 2017 | 247 | 2017 |
| Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis F Stegelmann, M Bastian, K Swoboda, R Bhat, V Kiessler, AM Krensky, ... The Journal of Immunology 175 (11), 7474-7483, 2005 | 122 | 2005 |
| Enhancement of NK cell antitumor responses using an oncolytic parvovirus R Bhat, S Dempe, C Dinsart, J Rommelaere International journal of cancer 128 (4), 908-919, 2011 | 105 | 2011 |
| Inverse correlation of maturity and antibacterial activity in human dendritic cells M Buettner, C Meinken, M Bastian, R Bhat, E Stössel, G Faller, ... The Journal of Immunology 174 (7), 4203-4209, 2005 | 81 | 2005 |
| Regulation of NK cell activity by 2B4, NTB-A and CRACC M Claus, S Meinke, R Bhat, C Watzl Front Biosci 13 (13), 956, 2008 | 63 | 2008 |
| Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment S Dempe, M Lavie, S Struyf, R Bhat, H Verbeke, S Paschek, N Berghmans, ... Cancer Immunology, Immunotherapy 61, 2113-2123, 2012 | 53 | 2012 |
| NK-cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by parvovirus infection of target cells R Bhat, J Rommelaere BMC cancer 13, 1-9, 2013 | 49 | 2013 |
| Fine-tuning of immune responses by SLAM-related receptors R Bhat, P Eissmann, J Endt, S Hoffmann, C Watzl Journal of leukocyte biology 79 (3), 417-424, 2006 | 49 | 2006 |
| Emerging role of Natural killer cells in oncolytic virotherapy R Bhat, J Rommelaere ImmunoTargets and therapy, 65-77, 2015 | 33 | 2015 |
| SARS-CoV-2: an overview of virus genetics, transmission, and immunopathogenesis MA Farrag, HM Amer, R Bhat, ME Hamed, IM Aziz, A Mubarak, ... International journal of environmental research and public health 18 (12), 6312, 2021 | 23 | 2021 |
| Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells X Yu, M Ilecka, EJ Bartlett, V Schneidt, R Bhat, J Mautner, R Feederle, ... Blood, The Journal of the American Society of Hematology 125 (10), 1601-1610, 2015 | 23 | 2015 |
| Double-edged role of natural killer cells during RSV infection R Bhat, MA Farrag, FN Almajhdi International reviews of immunology 39 (5), 233-244, 2020 | 19 | 2020 |
| Induction of immune responses and immune evasion by human bocavirus R Bhat, FN Almajhdi International Archives of Allergy and Immunology 182 (8), 728-735, 2021 | 13 | 2021 |
| Co-activation of cultured human natural killer cells: enhanced function and decreased inhibition D Urlaub, R Bhat, B Messmer, C Watzl Journal of Toxicology and Environmental Health, Part A 79 (22-23), 1078-1084, 2016 | 10 | 2016 |
| Sequence and phylogentic analysis of MERS-CoV in Saudi Arabia, 2012–2019 MA Farrag, HM Amer, R Bhat, FN Almajhdi Virology Journal 18 (1), 90, 2021 | 9 | 2021 |
| Durability of SARS-CoV-2 Specific IgG Antibody Responses Following Two Doses of Match and Mixed COVID-19 Vaccines Regimens in Saudi Population A Mubarak, S Almutairi, AD Al-Dhabbah, SY Aldabas, R Bhat, ... Infection and Drug Resistance, 3791-3800, 2022 | 7 | 2022 |
| ET-21 COMBINATION OF INTRAVENOUS AND INTRACEREBRAL INJECTION OF ONCOLYTIC PARVOVIRUS H-1 IN A PHASE I/IIA CLINICAL TRIAL OF PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME … K Geletneky, A Angelova, B Leuchs, R Bhat, A Just, D Capper, O Krebs, ... Neuro-oncology 16 (suppl_5), v83-v84, 2014 | 6 | 2014 |
| Development and Validation of Rapid In-House Diagnostic ELISA Kits for Detection of Human Orthopneumovirus in Clinical Samples IM Aziz, MA Farrag, R Bhat, A Ahmed, NA Alkubaisi, RM Alzayed, ... Diagnostics 12 (4), 912, 2022 | 1 | 2022 |
| Oncolytic Activity of Human Orthopneumovirus in Cancer Cell Lines IM Aziz, R Bhat, MA Farrag, FN Almajhdi Experimental Oncology 44 (2), 113-120, 2022 | 1 | 2022 |
